990 participants
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-17
- Start Date:
- 2025-12-31
- Completion:
- 2030-02-02
Conditions
- Untreated, Unresectable, or Metastatic Colorectal Cancer
Interventions
- DRUG
No Results Yet